12/10/2024
4:03 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:08 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:12 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:29 AM | Enanta Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
5:28 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:32 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:35 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:37 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:41 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:01 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:03 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/27/2024
4:04 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:06 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:08 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:10 PM | Enanta Pharmaceuticals (Issuer)
Kowalsky Matthew Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
7:35 AM | Enanta Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/25/2024
3:05 PM | Enanta Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:03 PM | ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/17/2024
3:31 PM | Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
08/09/2024
4:24 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:00 PM | Enanta Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
4:29 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
4:30 PM | Enanta Pharmaceuticals (Subject)
Rottinghaus Scott T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
7:38 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:23 PM | Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:27 PM | Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:30 PM | Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:15 PM | Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:19 PM | Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:12 PM | CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:31 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
12:11 PM | Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2024
7:21 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:23 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:00 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:09 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:12 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:15 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:18 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:26 PM | ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
11:15 PM | Enanta Pharmaceuticals (Filer)
| Form EFFECT | |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
01/26/2024
8:11 AM | Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
4:23 PM | BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
11:25 AM | Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
